318 related articles for article (PubMed ID: 24130797)
21. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
[TBL] [Abstract][Full Text] [Related]
22. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding.
Maretzky T; Evers A; Le Gall S; Alabi RO; Speck N; Reiss K; Blobel CP
J Biol Chem; 2015 Mar; 290(12):7416-25. PubMed ID: 25605720
[TBL] [Abstract][Full Text] [Related]
23. Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.
Minond D; Cudic M; Bionda N; Giulianotti M; Maida L; Houghten RA; Fields GB
J Biol Chem; 2012 Oct; 287(43):36473-87. PubMed ID: 22927435
[TBL] [Abstract][Full Text] [Related]
24. Phylogeny and expression of ADAM10 and ADAM17 homologs in lamprey.
Wu K; Xu J; Jia Z; Wang J; Wang Z; Feng J; Zhu X; Liu Q; Wang B; Li M; Pang Y; Zou J
Fish Physiol Biochem; 2023 Apr; 49(2):321-334. PubMed ID: 36964830
[TBL] [Abstract][Full Text] [Related]
25. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ
Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of the metalloproteinases ADAM10 or ADAM17 promotes osteoclast differentiation.
Babendreyer A; Kieselhorst J; Rinkens C; Lyashenko AM; Düsterhöft S; Jahr H; Craveiro RB; Wolf M; Ludwig A
Cell Commun Signal; 2024 Jun; 22(1):322. PubMed ID: 38863060
[TBL] [Abstract][Full Text] [Related]
27. L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth.
Maretzky T; Schulte M; Ludwig A; Rose-John S; Blobel C; Hartmann D; Altevogt P; Saftig P; Reiss K
Mol Cell Biol; 2005 Oct; 25(20):9040-53. PubMed ID: 16199880
[TBL] [Abstract][Full Text] [Related]
28. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
29. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.
Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML
Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658
[TBL] [Abstract][Full Text] [Related]
30. LC-MS based cleavage site profiling of the proteases ADAM10 and ADAM17 using proteome-derived peptide libraries.
Tucher J; Linke D; Koudelka T; Cassidy L; Tredup C; Wichert R; Pietrzik C; Becker-Pauly C; Tholey A
J Proteome Res; 2014 Apr; 13(4):2205-14. PubMed ID: 24635658
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17.
Alabi RO; Lora J; Celen AB; Maretzky T; Blobel CP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673337
[TBL] [Abstract][Full Text] [Related]
32. Metastasis-associated C4.4A, a GPI-anchored protein cleaved by ADAM10 and ADAM17.
Esselens CW; Malapeira J; Colomé N; Moss M; Canals F; Arribas J
Biol Chem; 2008 Aug; 389(8):1075-84. PubMed ID: 18979631
[TBL] [Abstract][Full Text] [Related]
33. Etoposide induces apoptosis and upregulation of TACE/ADAM17 and ADAM10 in an in vitro male germ cell line model.
Lizama C; Ludwig A; Moreno RD
Biochim Biophys Acta; 2011 Jan; 1813(1):120-8. PubMed ID: 20800622
[TBL] [Abstract][Full Text] [Related]
34. Role of ADAMs in the ectodomain shedding and conformational conversion of the prion protein.
Taylor DR; Parkin ET; Cocklin SL; Ault JR; Ashcroft AE; Turner AJ; Hooper NM
J Biol Chem; 2009 Aug; 284(34):22590-600. PubMed ID: 19564338
[TBL] [Abstract][Full Text] [Related]
35. Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases.
Gardiner EE; Karunakaran D; Shen Y; Arthur JF; Andrews RK; Berndt MC
J Thromb Haemost; 2007 Jul; 5(7):1530-7. PubMed ID: 17445093
[TBL] [Abstract][Full Text] [Related]
36. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
37. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
[TBL] [Abstract][Full Text] [Related]
38. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
39. Determination of the proteolytic cleavage sites of the amyloid precursor-like protein 2 by the proteases ADAM10, BACE1 and γ-secretase.
Hogl S; Kuhn PH; Colombo A; Lichtenthaler SF
PLoS One; 2011; 6(6):e21337. PubMed ID: 21695060
[TBL] [Abstract][Full Text] [Related]
40. Unsaturated fatty acids drive disintegrin and metalloproteinase (ADAM)-dependent cell adhesion, proliferation, and migration by modulating membrane fluidity.
Reiss K; Cornelsen I; Husmann M; Gimpl G; Bhakdi S
J Biol Chem; 2011 Jul; 286(30):26931-42. PubMed ID: 21642425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
